Global Bio-protein Drug Market Intelligence Report for Comprehensive Information 2017-2025

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 104
This report studies the global market size of Bio-protein Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bio-protein Drug in these regions.
This research report categorizes the global Bio-protein Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Bio-protein Drug market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Bio-protein Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Bio-protein Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Bio-protein Drug include
    Abbott Laboratories
    Bayer AG
    Eli Lilly and Company
    Amgen Inc.
    Biocon Ltd.
    Dr. Reddy’s Laboratories
    Roche
    Fresenius kabi
    GlaxoSmithKline
    Johnson & Johnson
    Merck
    Novartis AG
    Panacea Biotec
    ProBioGen AG
    Sanofi
    Reliance Life Science Pvt. Ltd.

Market Size Split by Type
    Monoclonal Antibodies
    Therapeutic Proteins
    Vaccines
Market Size Split by Application
    Pharma and Biotech Companies
    CROs
    Academics

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Bio-protein Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Bio-protein Drug market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Bio-protein Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Bio-protein Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Bio-protein Drug submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Bio-protein Drug are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio-protein Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Bio-protein Drug Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Bio-protein Drug Market Size Growth Rate by Type
        1.4.2 Monoclonal Antibodies
        1.4.3 Therapeutic Proteins
        1.4.4 Vaccines
    1.5 Market by Application
        1.5.1 Global Bio-protein Drug Market Size Growth Rate by Application
        1.5.2 Pharma and Biotech Companies
        1.5.3 CROs
        1.5.4 Academics
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Bio-protein Drug Market Size
        2.1.1 Global Bio-protein Drug Revenue 2016-2025
        2.1.2 Global Bio-protein Drug Sales 2016-2025
    2.2 Bio-protein Drug Growth Rate by Regions
        2.2.1 Global Bio-protein Drug Sales by Regions
        2.2.2 Global Bio-protein Drug Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Bio-protein Drug Sales by Manufacturers
        3.1.1 Bio-protein Drug Sales by Manufacturers
        3.1.2 Bio-protein Drug Sales Market Share by Manufacturers
        3.1.3 Global Bio-protein Drug Market Concentration Ratio (CR5 and HHI)
    3.2 Bio-protein Drug Revenue by Manufacturers
        3.2.1 Bio-protein Drug Revenue by Manufacturers (2016-2018)
        3.2.2 Bio-protein Drug Revenue Share by Manufacturers (2016-2018)
    3.3 Bio-protein Drug Price by Manufacturers
    3.4 Bio-protein Drug Manufacturing Base Distribution, Product Types
        3.4.1 Bio-protein Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Bio-protein Drug Product Category
        3.4.3 Date of International Manufacturers Enter into Bio-protein Drug  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Bio-protein Drug Sales by Type
    4.2 Global Bio-protein Drug Revenue by Type
    4.3 Bio-protein Drug Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Bio-protein Drug Breakdown Data by Application

6 North America
    6.1 North America Bio-protein Drug by Countries
        6.1.1 North America Bio-protein Drug Sales by Countries
        6.1.2 North America Bio-protein Drug Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Bio-protein Drug by Type
    6.3 North America Bio-protein Drug by Application
    6.4 North America Bio-protein Drug by Company

7 Europe
    7.1 Europe Bio-protein Drug by Countries
        7.1.1 Europe Bio-protein Drug Sales by Countries
        7.1.2 Europe Bio-protein Drug Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Bio-protein Drug by Type
    7.3 Europe Bio-protein Drug by Application
    7.4 Europe Bio-protein Drug by Company

8 Asia Pacific
    8.1 Asia Pacific Bio-protein Drug by Countries
        8.1.1 Asia Pacific Bio-protein Drug Sales by Countries
        8.1.2 Asia Pacific Bio-protein Drug Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Bio-protein Drug by Type
    8.3 Asia Pacific Bio-protein Drug by Application
    8.4 Asia Pacific Bio-protein Drug by Company

9 Central & South America
    9.1 Central & South America Bio-protein Drug by Countries
        9.1.1 Central & South America Bio-protein Drug Sales by Countries
        9.1.2 Central & South America Bio-protein Drug Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Bio-protein Drug by Type
    9.3 Central & South America Bio-protein Drug by Application
    9.4 Central & South America Bio-protein Drug by Company

10 Middle East and Africa
    10.1 Middle East and Africa Bio-protein Drug by Countries
        10.1.1 Middle East and Africa Bio-protein Drug Sales by Countries
        10.1.2 Middle East and Africa Bio-protein Drug Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Bio-protein Drug by Type
    10.3 Middle East and Africa Bio-protein Drug by Application
    10.4 Middle East and Africa Bio-protein Drug by Company

11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.1.4 Bio-protein Drug Product Description
        11.1.5 Recent Development
    11.2 Bayer AG
        11.2.1 Bayer AG Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.2.4 Bio-protein Drug Product Description
        11.2.5 Recent Development
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.3.4 Bio-protein Drug Product Description
        11.3.5 Recent Development
    11.4 Amgen Inc.
        11.4.1 Amgen Inc. Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.4.4 Bio-protein Drug Product Description
        11.4.5 Recent Development
    11.5 Biocon Ltd.
        11.5.1 Biocon Ltd. Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.5.4 Bio-protein Drug Product Description
        11.5.5 Recent Development
    11.6 Dr. Reddy’s Laboratories
        11.6.1 Dr. Reddy’s Laboratories Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.6.4 Bio-protein Drug Product Description
        11.6.5 Recent Development
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.7.4 Bio-protein Drug Product Description
        11.7.5 Recent Development
    11.8 Fresenius kabi
        11.8.1 Fresenius kabi Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.8.4 Bio-protein Drug Product Description
        11.8.5 Recent Development
    11.9 GlaxoSmithKline
        11.9.1 GlaxoSmithKline Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.9.4 Bio-protein Drug Product Description
        11.9.5 Recent Development
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Bio-protein Drug
        11.10.4 Bio-protein Drug Product Description
        11.10.5 Recent Development
    11.11 Merck
    11.12 Novartis AG
    11.13 Panacea Biotec
    11.14 ProBioGen AG
    11.15 Sanofi
    11.16 Reliance Life Science Pvt. Ltd.

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Bio-protein Drug Raw Material
        13.1.2 Bio-protein Drug Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Bio-protein Drug
    Figure Global Bio-protein Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Bio-protein Drug Production Market Share by Types (Product Category) in 2017
    Figure Monoclonal Antibodies Product Picture
    Table Major Manufacturers of Monoclonal Antibodies
    Figure Therapeutic Proteins Product Picture
    Table Major Manufacturers of Therapeutic Proteins
    Figure Vaccines Product Picture
    Table Major Manufacturers of Vaccines
    Table Global Bio-protein Drug Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Pharma and Biotech Companies
    Figure CROs
    Figure Academics
    Figure Bio-protein Drug Report Years Considered
    Figure Global Bio-protein Drug Market Size 2016-2025 (Million US$)
    Figure Global Bio-protein Drug Sales 2016-2025 (K Units)
    Table Global Bio-protein Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Bio-protein Drug Sales by Regions 2016-2025 (K Units)
    Table Global Bio-protein Drug Sales Market Share by Regions 2016-2025
    Figure Global Bio-protein Drug Sales Market Share by Regions 2016-2025
    Figure 2017 Global Bio-protein Drug Sales Market Share by Regions
    Table Global Bio-protein Drug Revenue by Regions 2016-2025 (Million US$)
    Table Global Bio-protein Drug Revenue Market Share by Regions 2016-2025
    Figure Global Bio-protein Drug Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Bio-protein Drug Revenue Market Share by Regions
    Table Global Bio-protein Drug Sales by Manufacturers (2016-2018) (K Units)
    Table Global Bio-protein Drug Sales Share by Manufacturers (2016-2018)
    Figure Global Bio-protein Drug Sales Share by Manufacturers in 2017
    Table Bio-protein Drug Revenue by Manufacturers (2016-2018) (Million US$)
    Table Bio-protein Drug Revenue Share by Manufacturers (2016-2018)
    Figure Bio-protein Drug Value Share by Manufacturers in 2017
    Table Global Bio-protein Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Bio-protein Drug Price (2016-2018) (USD/Unit)
    Table Bio-protein Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Bio-protein Drug Product Category
    Table Date of International Manufacturers Enter into Bio-protein Drug Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Bio-protein Drug Sales by Type (2016-2025) (K Units)
    Table Global Bio-protein Drug Sales Share by Type (2016-2025)
    Figure Global Bio-protein Drug Sales Market Share by Type (2016-2025)
    Figure Global Bio-protein Drug Sales Market Share by Type in 2017
    Table Global Bio-protein Drug Revenue by Type (2016-2025) (Million US$)
    Table Global Bio-protein Drug Revenue Share by Type (2016-2025)
    Figure Global Bio-protein Drug Revenue Market Share by Type (2016-2025)
    Figure Global Bio-protein Drug Revenue Market Share by Type in 2017
    Table Bio-protein Drug Price by Type 2013-2018 (USD/Unit)
    Table Global Bio-protein Drug Sales by Application (2016-2025) (K Units)
    Table Global Bio-protein Drug Sales Share by Application (2016-2025)
    Figure Global Sales Bio-protein Drug Market Share by Application (2016-2025)
    Figure Global Sales Bio-protein Drug Market Share by Application (2016-2025)
    Figure North America Bio-protein Drug Sales Growth Rate 2016-2025 (K Units)
    Figure North America Bio-protein Drug Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Bio-protein Drug Sales by Countries (2016-2025) (K Units)
    Table North America Bio-protein Drug Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Bio-protein Drug Sales Market Share by Countries
    Table North America Bio-protein Drug Revenue by Countries (2016-2025) (Million US$)
    Table North America Bio-protein Drug Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Bio-protein Drug Revenue Market Share by Countries
    Figure United States Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure United States Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Bio-protein Drug Sales by Type (2016-2025) (K Units)
    Table North America Bio-protein Drug Sales Market Share by Type (2016-2025)
    Figure 2017 North America Bio-protein Drug Market Share by Type
    Table North America Bio-protein Drug Sales by Application (2016-2025) (K Units)
    Table North America Bio-protein Drug Sales Market Share by Application (2016-2025)
    Figure 2017 North America Bio-protein Drug Market Share by Application
    Table North America Bio-protein Drug Sales by Company (2016-2018) (K Units)
    Table North America Bio-protein Drug Sales Market Share by Company (2016-2018)
    Figure North America Bio-protein Drug Sales Market Share by Company in 2017
    Figure Europe Bio-protein Drug Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Bio-protein Drug Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Bio-protein Drug Sales by Countries (2016-2025) (K Units)
    Table Europe Bio-protein Drug Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Bio-protein Drug Sales Market Share by Countries
    Table Europe Bio-protein Drug Revenue by Countries (2016-2025) (Million US$)
    Table Europe Bio-protein Drug Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Bio-protein Drug Revenue Market Share by Countries
    Figure Germany Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Bio-protein Drug Revenue Growth Rate (2016-2025) (K Units)
    Figure France Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure France Bio-protein Drug Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure UK Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Bio-protein Drug Sales by Type (2016-2025) (K Units)
    Table Europe Bio-protein Drug Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Bio-protein Drug Market Share by Type
    Table Europe Bio-protein Drug Sales by Application (2016-2025) (K Units)
    Table Europe Bio-protein Drug Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Bio-protein Drug Market Share by Application
    Table Europe Bio-protein Drug Sales by Company (2016-2018) (K Units)
    Table Europe Bio-protein Drug Sales Market Share by Company (2016-2018)
    Figure Europe Bio-protein Drug Sales Market Share by Company in 2017
    Figure Asia Pacific Bio-protein Drug Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Bio-protein Drug Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Bio-protein Drug Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Bio-protein Drug Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Bio-protein Drug Sales Market Share by Countries
    Table Asia Pacific Bio-protein Drug Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Bio-protein Drug Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Bio-protein Drug Revenue Market Share by Countries
    Figure China Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure China Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure India Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Bio-protein Drug Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Bio-protein Drug Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Bio-protein Drug Market Share by Type
    Table Asia Pacific Bio-protein Drug Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Bio-protein Drug Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Bio-protein Drug Market Share by Application
    Table Asia Pacific Bio-protein Drug Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Bio-protein Drug Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Bio-protein Drug Sales Market Share by Company in 2017
    Figure Central & South America Bio-protein Drug Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Bio-protein Drug Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Bio-protein Drug Sales by Countries (2016-2025) (K Units)
    Table Central & South America Bio-protein Drug Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Bio-protein Drug Sales Market Share by Countries
    Table Central & South America Bio-protein Drug Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Bio-protein Drug Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Bio-protein Drug Revenue Market Share by Countries
    Figure Brazil Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Bio-protein Drug Sales by Type (2016-2025) (K Units)
    Table Central & South America Bio-protein Drug Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Bio-protein Drug Market Share by Type
    Table Central & South America Bio-protein Drug Sales by Application (2016-2025) (K Units)
    Table Central & South America Bio-protein Drug Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Bio-protein Drug Market Share by Application
    Table Central & South America Bio-protein Drug Sales by Company (2016-2018) (K Units)
    Table Central & South America Bio-protein Drug Sales Market Share by Company (2016-2018)
    Figure Central & South America Bio-protein Drug Sales Market Share by Company in 2017
    Figure Middle East and Africa Bio-protein Drug Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Bio-protein Drug Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Bio-protein Drug Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Bio-protein Drug Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Bio-protein Drug Sales Market Share by Countries
    Table Middle East and Africa Bio-protein Drug Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Bio-protein Drug Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Bio-protein Drug Revenue Market Share by Countries
    Figure GCC Countries Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Bio-protein Drug Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Bio-protein Drug Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Bio-protein Drug Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Bio-protein Drug Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Bio-protein Drug Market Share by Type
    Table Middle East and Africa Bio-protein Drug Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Bio-protein Drug Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Bio-protein Drug Market Share by Application
    Table Middle East and Africa Bio-protein Drug Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Bio-protein Drug Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Bio-protein Drug Sales Market Share by Company in 2017
    Table Abbott Laboratories Company Details
    Table Abbott Laboratories Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Abbott Laboratories Recent Development
    Table Bayer AG Company Details
    Table Bayer AG Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Bayer AG Recent Development
    Table Eli Lilly and Company Company Details
    Table Eli Lilly and Company Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Eli Lilly and Company Recent Development
    Table Amgen Inc. Company Details
    Table Amgen Inc. Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Amgen Inc. Recent Development
    Table Biocon Ltd. Company Details
    Table Biocon Ltd. Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Biocon Ltd. Recent Development
    Table Dr. Reddy’s Laboratories Company Details
    Table Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Dr. Reddy’s Laboratories Recent Development
    Table Roche Company Details
    Table Roche Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Roche Recent Development
    Table Fresenius kabi Company Details
    Table Fresenius kabi Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Fresenius kabi Recent Development
    Table GlaxoSmithKline Company Details
    Table GlaxoSmithKline Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table GlaxoSmithKline Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Bio-protein Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Johnson & Johnson Recent Development
    Table Merck Company Details
    Table Novartis AG Company Details
    Table Panacea Biotec Company Details
    Table ProBioGen AG Company Details
    Table Sanofi Company Details
    Table Reliance Life Science Pvt. Ltd. Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Bio-protein Drug Value Chain
    Table Typical Suppliers of Key Bio-protein Drug Raw Material
    Table Bio-protein Drug Customers List
    Table Bio-protein Drug Sales Channels
    Table Bio-protein Drug Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...

22-Mar-2018 | Service

Indian SMEs Can Now Opt For WhatsApp Business App For Better Connectivity

WhatsApp, a “Facebook” owned mobile-based application, has introduced its innovative and efficient feature “WhatsApp Business App” ...